Stock List

Search by Ticker



Neogenomics (NasdaqCM:NEO)
Stock Analysis

▼ -0.35%-0.135

Stock Analysis

The following stock analysis is based on 7.4 years of data (i.e. since Mar 18, 2013). All the stock history has been downloaded.

Stock Exchange

Neogenomics trades on the NasdaqCM exchange in USD dollars.


It is in the healthcare sector.

Current Status of Neogenomics

It is currently trading at $38.465 ($38.6 the previous day).


The next reporting date is in 90 days (2020 11 03).

CNN estimates profits for the upcoming quarter will be $0.04 per share ($127.6M). The current Canada / US exchange rate is 1.3378.

Over the past 12 months, $0 worth of shares have been purchased and $35186262 worth of shares have been sold by insiders.

Will This Trend Continue?

The year over year average increase is 46.3% per year assuming steady exponential growth. The actual 5 year average is 42.86. Details on the individual increase in one year intervals is provided below.

Past PerformanceAverage PricePercent Change
1 year27.45386330935353.1+ Above Average
2 year17.92879032258178.9+ Above Average
3 year10.01933609958520.2- Below Average
4 year8.336408163265313.3- Below Average
5 year7.355496183206148.8+ Above Average
Neogenomics is projected by analysts to get to $40.00 within the next 12 months (4%), but preticted targets range from as high as $45.00 (17%) and as low as $39(1.4%).


The worst drop it has had in recent years is -49.6%. It has a few bumps shape to the stock curve, which means the stock generally continues on a consistent trend and does not have to be checked often, but can have some variation during periods of volitility.

Stock shape test


With an average increase of 46.3% year over year, if Neogenomics is bought at the worst time, Stockmarketizer analysts estimate it will take 12.9 months before the stock will recover to the original purchase price.

Tradingview BuySell Widget

Yahoo News Feed

NeoGenomics, Inc. (NASDAQ:NEO) Just Reported Second-Quarter Earnings And Analysts Are Lifting Their Estimates

Thu, 30 Jul 2020 14:52:20 Itand's been a good week for NeoGenomics, Inc. (NASDAQ:NEO) shareholders, because the company has just released its...... Read Full Article

Neogenomics Inc (NEO) Q2 2020 Earnings Call Transcript

Tue, 28 Jul 2020 17:30:50 Joining me from our Fort Myers headquarters, with social distancing precautions in place, are Kathryn McKenzie, our Chief Financial Officer; Rob Shovlin, President of our Clinical Division; and Bill Bonello, President of our Informatics Division and Director of Investor Relations. ...... Read Full Article

Recap: NeoGenomics Q2 Earnings

Tue, 28 Jul 2020 14:34:15 Shares of NeoGenomics (NASDAQ:NEO) rose 1% after the company reported Q2 results.Quarterly Results Earnings per share fell 157.14% over the past year to ($0.04), which beat the estimate of ($0.10).Revenue of $86,977,000 decreased by 14.49% from the same period last year, which beat ...... Read Full Article

NeoGenomics (NEO) Reports Q2 Loss, Tops Revenue Estimates

Tue, 28 Jul 2020 13:55:01 NeoGenomics (NEO) delivered earnings and revenue surprises of 55.56% and 1.01%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?... Read Full Article

What Can We Conclude About NeoGenomicsand' (NASDAQ:NEO) CEO Pay?

Tue, 28 Jul 2020 12:59:37 This article will reflect on the compensation paid to Doug VanOort who has served as CEO of NeoGenomics, Inc...... Read Full Article

NeoGenomics Reports Revenue of $87 Million in the Second Quarter amid COVID-19 Pandemic

Tue, 28 Jul 2020 11:00:00 (NASDAQ:NEO) (the and"Companyand"), a leading provider of cancer-focused genetics testing services, today announced its second-quarter results for the period ended June 30, 2020.... Read Full Article

Earnings Preview: NeoGenomics (NEO) Q2 Earnings Expected to Decline

Tue, 21 Jul 2020 16:31:04 NeoGenomics (NEO) doesnand't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.... Read Full Article

NeoGenomics Announces Board Appointments

Mon, 20 Jul 2020 11:00:00 FT MYERS, FL / ACCESSWIRE / July 20, 2020 / NeoGenomics, Inc.... Read Full Article

3 Top Healthcare Stocks to Buy Right Now

Sun, 12 Jul 2020 10:12:00 Investors often consider the healthcare sector a "defensive" one because people get sick in good economic times and bad. The healthcare sector has been thrown into turmoil with stay-at-home orders and clinic closures. BioNTech (NASDAQ: BNTX), NeoGenomics (NASDAQ: NEO), and ...... Read Full Article

Hedge Funds Are Souring On NeoGenomics, Inc. (NEO)

Sun, 05 Jul 2020 00:18:34 The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data. We at Insider Monkey have plowed through 821 13F filings that hedge ...... Read Full Article

NeoGenomics Schedules its Second Quarter Earnings Release for July 28, 2020

Wed, 01 Jul 2020 11:00:00 FT. MYERS, FL / ACCESSWIRE / July 1, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today that it plans to release its second quarter 2020 ...... Read Full Article

NeoGenomics Launches Comprehensive Suite of Solid Tumor Liquid Biopsy Tests for Cancer Patients

Mon, 29 Jun 2020 11:00:00 FT. MYERS, FL / ACCESSWIRE / June 29, 2020 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services, announced today the launch of three liquid biopsy tests for advanced ...... Read Full Article

Benzingaand's Top Upgrades, Downgrades For June 25, 2020

Thu, 25 Jun 2020 14:10:26 Upgrades * Credit Suisse changed the rating for Allstate Corp (NYSE: ALL) from Underperform to Neutral. Allstate earned $3.54 in the first quarter, compared to $2.30 in the year-ago quarter. The stock has a 52-week-high of $125.92 and a 52-week-low of $64.13. Allstateand's stock last ...... Read Full Article

Needham: 3 Conviction Buy Stocks to Snap up Now

Thu, 18 Jun 2020 16:27:01 For investors feeling perplexed by the stock market’s roller coaster ride in 2020, you’re not alone. Following up a week that saw volatility make a comeback, stocks popped for the third session in a row on June 16, surging on ...... Read Full Article

Edited Transcript of NEO earnings conference call or presentation 28-Apr-20 12:30pm GMT

Fri, 12 Jun 2020 05:50:28 Q1 2020 Neogenomics Inc Earnings Call... Read Full Article

Edited Transcript of NEO earnings conference call or presentation 27-Feb-20 1:30pm GMT

Tue, 19 May 2020 04:00:58 Q4 2019 Neogenomics Inc Earnings Call... Read Full Article

2 Stocks to Buy and Hold for Decades

Sat, 09 May 2020 15:47:00 Investing in stocks might not make you rich overnight, or even over the course of a few years. With that in mind, here are two top stocks that you can buy and hold for a long time: NeoGenomics (NASDAQ: NEO) ...... Read Full Article

NeoGenomics and Bayer Collaborate to Offer NTRK Testing for Certain Colorectal and Thyroid Cancer Patients

Tue, 05 May 2020 12:00:00 MYERS, FL / ACCESSWIRE / May 5, 2020 / NeoGenomics, Inc. (NEO), a leading provider of cancer-focused genetic testing services, today announced a collaboration with Bayer (BAYN) to facilitate an RNA-based Neurotrophic Tropomyosin-Receptor Kinase (NTRK) testing for certain colorectal and thyroid cancer patients. All eligible ...... Read Full Article

Hereand's Why NeoGenomics Is Tumbling Today

Thu, 30 Apr 2020 16:07:00 The company decided to pull the trigger on a combined offering of stock and debt to pad its balance sheet during uncertain times.... Read Full Article

NeoGenomics Announces Pricing of Public Offerings of Common Stock and Convertible Senior Notes

Thu, 30 Apr 2020 10:00:00 FORT MYERS, FL / ACCESSWIRE / April 30, 2020 / NeoGenomics, Inc. (NASDAQ:NEO) (the " Company " ), a leading provider of cancer-focused genetics testing services, today announced the pricing of ...... Read Full Article